These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 19429429)

  • 1. Selective inhibition of 11beta-hydroxysteroid dehydrogenase 1 by 18alpha-glycyrrhetinic acid but not 18beta-glycyrrhetinic acid.
    Classen-Houben D; Schuster D; Da Cunha T; Odermatt A; Wolber G; Jordis U; Kueenburg B
    J Steroid Biochem Mol Biol; 2009 Feb; 113(3-5):248-52. PubMed ID: 19429429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of activity and binding mode of glycyrrhetinic acid derivatives inhibiting 11β-hydroxysteroid dehydrogenase type 2.
    Kratschmar DV; Vuorinen A; Da Cunha T; Wolber G; Classen-Houben D; Doblhoff O; Schuster D; Odermatt A
    J Steroid Biochem Mol Biol; 2011 May; 125(1-2):129-42. PubMed ID: 21236343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of novel 3-amino and 29-hydroxamic acid derivatives of glycyrrhetinic acid as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
    Stanetty C; Czollner L; Koller I; Shah P; Gaware R; Cunha TD; Odermatt A; Jordis U; Kosma P; Classen-Houben D
    Bioorg Med Chem; 2010 Nov; 18(21):7522-41. PubMed ID: 20851614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of new glycyrrhetinic acid derived ring A azepanone, 29-urea and 29-hydroxamic acid derivatives as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
    Gaware R; Khunt R; Czollner L; Stanetty C; Da Cunha T; Kratschmar DV; Odermatt A; Kosma P; Jordis U; Classen-Houben D
    Bioorg Med Chem; 2011 Mar; 19(6):1866-80. PubMed ID: 21376605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human and rat 11beta-hydroxysteroid dehydrogenase type 1 by 18beta-glycyrrhetinic acid derivatives.
    Su X; Vicker N; Lawrence H; Smith A; Purohit A; Reed MJ; Potter BV
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):312-20. PubMed ID: 17493801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous inhibitors (GALFs) of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2: derivatives of adrenally produced corticosterone and cortisol.
    Morris DJ; Latif SA; Hardy MP; Brem AS
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):161-8. PubMed ID: 17459698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of the cancer-associated glucocorticoid system: key role of 11β-hydroxysteroid dehydrogenase type 2.
    Cirillo N; Morgan DJ; Pedicillo MC; Celentano A; Lo Muzio L; McCullough MJ; Prime SS
    Br J Cancer; 2017 Sep; 117(7):984-993. PubMed ID: 28797028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of 11alpha-deuterium labeled cortisol as a tracer for assessing reduced 11beta-HSD2 activity in vivo following glycyrrhetinic acid ingestion in a human subject.
    Kasuya Y; Yokokawa A; Takashima S; Shibasaki H; Furuta T
    Steroids; 2005 Feb; 70(2):117-25. PubMed ID: 15631868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of 11β-hydroxysteroid dehydrogenase 1 and 2 in patients with chronic rhinosinusitis and their possible contribution to local glucocorticoid activation in sinus mucosa.
    Jun YJ; Park SJ; Kim TH; Lee SH; Lee KJ; Hwang SM; Lee SH
    J Allergy Clin Immunol; 2014 Oct; 134(4):926-934.e6. PubMed ID: 24810847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel 11β-HSD1 inhibitors by combined ligand- and structure-based virtual screening.
    Lagos CF; Vecchiola A; Allende F; Fuentes CA; Tichauer JE; Valdivia C; Solari S; Campino C; Tapia-Castillo A; Baudrand R; Villarroel P; Cifuentes M; Owen GI; Carvajal CA; Fardella CE
    Mol Cell Endocrinol; 2014 Mar; 384(1-2):71-82. PubMed ID: 24447464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-Monoglucuronyl-glycyrrhretinic acid is a substrate of organic anion transporters expressed in tubular epithelial cells and plays important roles in licorice-induced pseudoaldosteronism by inhibiting 11β-hydroxysteroid dehydrogenase 2.
    Makino T; Okajima K; Uebayashi R; Ohtake N; Inoue K; Mizukami H
    J Pharmacol Exp Ther; 2012 Aug; 342(2):297-304. PubMed ID: 22543032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 11{beta}-Hydroxysteroid dehydrogenase 2 in rat leydig cells: its role in blunting glucocorticoid action at physiological levels of substrate.
    Ge RS; Dong Q; Niu EM; Sottas CM; Hardy DO; Catterall JF; Latif SA; Morris DJ; Hardy MP
    Endocrinology; 2005 Jun; 146(6):2657-64. PubMed ID: 15761036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered activity of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in skeletal muscle confers metabolic protection in subjects with type 2 diabetes.
    Jang C; Obeyesekere VR; Dilley RJ; Krozowski Z; Inder WJ; Alford FP
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3314-20. PubMed ID: 17519316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of glycyrrhetinic acid derivatives on hepatic and renal 11beta-hydroxysteroid dehydrogenase activities in rats.
    Shimoyama Y; Hirabayashi K; Matsumoto H; Sato T; Shibata S; Inoue H
    J Pharm Pharmacol; 2003 Jun; 55(6):811-7. PubMed ID: 12841942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 11Beta-hydroxysteroid dehydrogenase type 2 and the regulation of surfactant protein A by dexamethasone metabolites.
    Garbrecht MR; Schmidt TJ; Krozowski ZS; Snyder JM
    Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E653-60. PubMed ID: 16263772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of 11β-hydroxysteroid dehydrogenase enzymes in human osteosarcoma: potential role in pathogenesis and as targets for treatments.
    Patel P; Hardy R; Sumathi V; Bartle G; Kindblom LG; Grimer R; Bujalska I; Stewart PM; Rabbitt E; Gittoes NJ; Cooper MS
    Endocr Relat Cancer; 2012 Aug; 19(4):589-98. PubMed ID: 22719058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of 11β-hydroxysteroid dehydrogenase type 1 and 2 in mild and moderate/severe persistent allergic nasal mucosa and regulation of their expression by Th2 cytokines: asthma and rhinitis.
    Jun YJ; Park SJ; Hwang JW; Kim TH; Jung KJ; Jung JY; Hwang GH; Lee SH; Lee SH
    Clin Exp Allergy; 2014 Feb; 44(2):197-211. PubMed ID: 24447082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel 18beta-glycyrrhetinic acid analogues as potent and selective inhibitors of 11beta-hydroxysteroid dehydrogenases.
    Su X; Lawrence H; Ganeshapillai D; Cruttenden A; Purohit A; Reed MJ; Vicker N; Potter BV
    Bioorg Med Chem; 2004 Aug; 12(16):4439-57. PubMed ID: 15265495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 11β-hydroxysteroid dehydrogenase inhibition as a new potential therapeutic target for alcohol abuse.
    Sanna PP; Kawamura T; Chen J; Koob GF; Roberts AJ; Vendruscolo LF; Repunte-Canonigo V
    Transl Psychiatry; 2016 Mar; 6(3):e760. PubMed ID: 26978742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of 11β-hydroxysteroid dehydrogenase type 2 in lymphoblastic cells and its relationship with glucocorticoid sensitivity].
    Tao Y; Shi JM; Zhang YX; Gao L; Zhan FH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):109-13. PubMed ID: 21362233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.